Nanomedicine Market - Global Industry Analysis, Size, Share,Growth, Trends and Forecast, 2013 - 2019
This
report includes market estimations and forecast for nanomedicine
products for the forecast period 2013 – 2019. The market size is
represented in terms of USD billion and the market estimates and
forecasts are calculated, considering 2012 as the base year.
Moreover, market trends and recent developments have been kept into
account while forecasting market growth and revenue for the period
2013 – 2019. The stakeholders for this report include present
market players in the global nanomedicine market who aspire to
increase their market share. Moreover, this report also targets the
new players desiring to enter the global nanomedicine market.
Browse Here For Full Report and
ToC:http://www.transparencymarketresearch.com/nanomedicine-market.html
This
report focuses on nanomedicine based products used for the purpose of
various medical applications. Development of a nanomedicine takes
years, incurring huge monetary investment. The product development
process detailed in the market overview section of this report
provides insights on the different events in the product development
process with an approximate number of years consumed for that.
According to this study, development of a new nenomedicine takes
approximately nine to 25 years which are based on various
technologies such as nanopores, liposomes, nanocrystals, virosome
nanoparticles, nanorods, dendrimers, micelles, nanoemulsions, quantum
dots, fullerenes and nanorobots.
“We are currently offering a flat 15% discount on all purchases
until end of the March 2015!”
The
market dynamics section of this report analyzes the impact of drivers
and restraints on the global nanomedicine market. The impact of these
drivers and restraints on the global nanomedicine market provides a
view on the market growth during the course of the forecast period.
Increasing research activities to improve the drug efficacy coupled
with increasing government support are considered to be some of the
major driving factors in this report. Moreover, few significant
opportunities for the existing and new market players are detailed in
this report.
Porter’s
five forces analysis provides insights on the intensity of
competition which can aid in decision making for investments in the
global nanomedicine market. The market attractiveness section of this
report provides a graphical representation for attractiveness of the
nanomedicine market in four major regions – North America, Europe,
Asia-Pacific and Rest of the World, based on the market size, growth
rate and industrial environment in respective regions, in 2012.
Click Here For Press Release Of this Report
:http://www.transparencymarketresearch.com/pressrelease/nanomedicine-market.htm
The
global nanomedicine market is segmented on the basis of application
and geography and the market size for each of these segments, in
terms of USD billion, is provided in this report for the period 2011
– 2019. Market forecast for this applications and geographies is
provided for the period 2013 – 2019, considering 2012 as the base
year.
Based
on the type of applications, the global nanomedicine market is
segmented into neurological, cardiovascular, oncology,
anti-inflammatory, anti-infective and other applications. Other
applications include dental, hematology, orthopedic, kidney diseases,
ophthalmology, and other therapeutic and diagnostic applications of
nanomedicines. Nanoparticle based medications are available globally,
which are aimed at providing higher bioavilability and hence
improving the efficacy of drug. There have been increasing research
activities in the nanomedicine filed for neurology, cardiovascular
and oncology applications to overcome the barriers in efficient drug
delivery to the target site. Moreover, the global nanomedicine market
is also estimated and analyzed on the basis of geographic regions
such as North America, Europe, Asia-Pacific and Rest of the World.
This section describes the nanomedicine support activities and
products in respective regions, thus determining the market dynamics
in these regions.
The
report also provides a few recommendations for the exisitng as well
as new players to increase their market share in the global
nanomedicine market. Some of the key players of this market include
GE Healthcare, Mallinckrodt plc, Nanosphere Inc., Pfizer Inc., Merck
& Co Inc., Celgene Corporation, CombiMatrix Corporation, Abbott
Laboratories and others. The role of these market players in the
global nanomedicine market is analyzed by profiling them on the basis
of attributes such as company overview, financial overview, product
portfolio, business strategies, and recent developments.
Browse Here For Upcoming
Reports:http://www.transparencymarketresearch.com/medical-devices-market-reports-6.html
The
global nanomedicine market is categorized into the following
segments:
Nanomedicine
Market by Application
Neurology
Cardiovascular
Anti-Inflammatory
Anti-Infectives
Oncology
Others
Nanomedicine
Market by Geography
North
America
Europe
Asia-Pacific
Rest
of the World (RoW)
About Us :
Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers.
We are privileged with highly experienced team of Analysts, Researchers and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge
Contact Us:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http:/www.transparencymarketresearch.com/
Molecular Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
Molecular
diagnostics is defined as a class of diagnostic tests which
identifies genetic and molecular biomarkers of an individual patient.
It is essentially an analysis of RNA and DNA at the molecular level.
This class of diagnostics tests is considered as the most well
established and lucrative market in the clinical applications
segment. Traditionally, usage of molecular diagnostics was limited
due to requirement of highly skilled professionals and high cost of
tests. However, recent reduction in cost per sample analysis, labor
costs, improvements in automation and introduction of advanced
technologies have expanded the usage of molecular diagnostics tests.
The growth of this market is expected to surge due to various factors
such as rise in incidence of hospital acquired infections, increase
in patient awareness along with growing elderly population.
Additionally, outbreak of diseases such as H1N1, growing incidence of
diseases such as HIV and hepatitis have augmented the growth of this
market.
Click Here For full Report with
ToC:http://www.transparencymarketresearch.com/molecular-diagnostics-industry.html
The
research report on molecular diagnostics provides detailed analysis
of the global market and helps in understanding the driving forces
responsible for its growth. The report discusses the molecular
diagnostics market on the basis of different technologies and
applications. The technology segment comprises polymerase chain
reaction (PCR), transcription mediated amplification (TMA),
hybridization technique, microarray, next generation sequencing and
others. The application segment is classified into infectious
diseases, blood donor screening and genomics. The genomics segmented
is further classified into genetic disorders testing, oncology
testing, HLA testing and pharmacogenetic testing. The infectious
diseases segment is subsegmented into virology and bacteriology. The
virology section of the report deals with testing of following
infections namely, HIV (Human immunodeficiency virus), HPV (Human
papillomavirus), HCV (Hepatitis C virus) and others. The bacteriology
segment of the report is further categorized into hospital acquired
infections (HAI), CT/NG (Chlamydia trachomatis and Neisseria
gonorrhoeae) and others. Market size estimates and forecasts for the
period 2011 to 2019 have been provided for each of the segments in
terms of USD million using 2012 as the base year. The CAGR (%) of
each market segment for the forecast period 2013 to 2019 has been
provided along with market size estimations.
We
are currently offering a flat 15% discount on all purchases until end
of the March 2015!
The
molecular diagnostics market has also been segmented geographically
into four regions: North America, Europe, Asia Pacific and Rest of
the World (RoW), and respective market sizes and forecasts have been
provided for each of these regions. A detailed qualitative analysis
of the factors responsible for driving and restraining the growth of
the global molecular diagnostics market, and future opportunities has
been provided in the market overview section. This section also
features a detailed market attractiveness analysis and Porter’s
five forces analysis for the molecular diagnostics market that would
help in determining the degree of competition in the market. The
entire section of market overview plays an important role in
understanding the market on a global level. Further, the report on
molecular diagnostics also provides executive summary that that will
help you understand the overall market size, growth rate of various
segments, geographies and competitors present in the market in a very
precise manner.
Click Here For Press release of this
Report:http://www.transparencymarketresearch.com/pressrelease/molecular-diagnostics-market.htm
The
molecular diagnostics market report also provides a highlight of the
competitive landscape of the market wherein the market share analysis
of the leading players in the market, in terms of percentage share in
2012 has been discussed. A list of recommendations has also been
included for new entrants as well as existing market players to help
them establish a strong presence in the market and accentuate market
shares. The report concludes with the profiles of major players in
the molecular diagnostics market such as Abbott Laboratories, Becton
Dickinson & Company, Cepheid, Roche Diagnostics and others.
Profiles of these players have been extensively analyzed on the basis
of company overview, financial overview, business strategies, product
portfolio and recent developments.
The
global molecular diagnostics market is segmented into the following
categories:
Molecular
Diagnostics Market, by Technology
- PCR
- Transcription mediated amplification (TMA)
- Next generation sequencing
- Microarray
- Hybridization techniques
- Others
Molecular
Diagnostics Market, by Application
- Infectious diseases
- Virology
- HIV testing
- HPV testing
- HCV testing
- Others
- Bacteriology
- HAI testing
- CT/NG testing
- Others
- Genomics
- Genetic testing for inherited disorders
- Human Leukocyte Antigen (HLA) testing
- Pharmacogenetics testing
- Oncology Testing
- Blood Donor Screening
- Others
Molecular
Diagnostics Market, by Geography
- North America
- Europe
- Asia-Pacific
- RoW
About Us :
Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers.
We are privileged with highly experienced team of Analysts, Researchers and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge
Contact Us:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http:/www.transparencymarketresearch.com/
Minimally Invasive Surgery Market-Global Industry Analysis and Forecast 2013 - 2019
Minimally
invasive surgeries are intended to be performed with minimal incision
made in the patient’s body and ensure quick recovery along with
minimal duration of hospital stay. Minimally invasive surgeries are
now increasingly gaining importance and preference over conventional
invasive surgeries due to the multiple benefits associated with these
surgeries including reduced recovery time, minima patient trauma,
reduced duration of hospital stay, and hence, the overall cost of
treatment. The market is also expected to grow owing to rising
prevalence of various diseases such as cancer, for which minimally
invasive surgery is a treatment option. This would undoubtedly
enhance the growth of minimally invasive surgery market. The devices
utilized for performing minimally invasive surgeries mainly include
ablation devices, electrosurgical devices, medical robotic systems
and endoscopy devices.
Browse Here For Full Report With
ToC:http://www.transparencymarketresearch.com/minimally-invasive-surgery-market.html
This
report studies the global minimally invasive surgery (MIS) market
from three perspectives, namely, types of devices used in performing
these surgeries, various types of surgeries performed and the major
geographic markets. The global market for MIS has been segmented into
three main categories of devices that include surgical devices,
monitoring and visualization devices, and endoscopy devices. Surgical
devices are further classified as ablation devices, electrosurgical
devices, and medical robotic systems. Similarly, the monitoring and
visualization devices market has also been segmented into MRI
equipment, CT scanners, X-ray devices, ultrasound equipment and other
(PET and SPECT scanners, and combination devices such as PET/CT,
PET/MRI, SPECT/CT, and SPECT/MRI). The market for this segment has
been extensively analyzed based on number of installed base of these
imaging modalities, reimbursement scenario and cost. The market size
and forecast in terms of USD million for each product type has been
provided for the period 2011 to 2019, considering 2012 as the base
year. The report also provides the compounded annual growth rate (%
CAGR) for the forecast period 2013 to 2019 for each segment
“We are currently offering a flat 15%
discount on all purchases until end of the March 2015!”
The
various types of minimally invasive surgeries performed have also
been provided in the report. The global market for minimally invasive
surgery has been segmented into orthopedic surgery (spinal surgery
and joint replacement surgery), cosmetic surgery, breast surgery,
vascular surgery, thoracic surgery, gynecological surgery, bariatric
surgery, cardiac surgery, gastrointestinal surgery and urological
surgery. Geographically, the report segments the global market into
four main regions, namely, North America, Europe, Asia-Pacific and
Rest of the World (RoW). The market for all the aforementioned
segments has been extensively analyzed based on number of surgeries,
number of diseases, technological advancements in surgical equipment,
reimbursement scenario and cost. The market size and forecast in
terms of USD million for each product type has been provided for the
period 2011 to 2019, considering 2012 as the base year. The report
also provides the compounded annual growth rate (% CAGR) for the
forecast period 2013 to 2019 for each segment.
Click Here For Press Release Of This
Report:http://www.transparencymarketresearch.com/pressrelease/minimally-invasive-surgery-market.htm
The
market overview section of the report discusses the market dynamics
with respect to market drivers, restraints and opportunities. This
section also covers a market attractiveness analysis (by geography)
and Porter’s five forces analysis for the global minimally invasive
surgery market. Market share (%) for the major players operating in
this market has also been provided for the year 2012, followed by a
list of recommendations for the existing and new players to enter and
enhance their market shares and enter the market respectively. The
report concludes with the company profiles of key players operating
in various segments of the market. Each company profile includes the
business overview, financial overview, product portfolio, business
strategies and recent developments of the respective company. Some of
the prominent players in the minimally invasive surgery market that
have been profiled in this report include Intuitive Surgical, Inc.,
GE Healthcare, Philips Healthcare, Siemens Healthcare, Medtronic,
Inc., Stryker Corporation, Biomet, Inc. and DePuy Synthes, Inc.
The
global minimally invasive surgery market has been segmented as below:
Minimally
Invasive Surgery Market, by Product Types
- Surgical Devices
- Ablation Devices
- Radiofrequency Ablation
- Microwave Ablation
- Cryoablation
- Others
- Electrosurgical Devices
- Medical Robotic Systems
- Monitoring & Visualization Devices
- X-Ray Devices
- Computed Tomography (CT) Scanners
- Magnetic Resonance Imaging (MRI) Equipment
- Ultrasound Equipment
- Others
- Endoscopy Devices
Minimally
Invasive Surgery Market, by Type of Surgery
- Orthopedic Surgery
- Spinal Surgery
- Joint Replacement Surgery
- Cosmetic Surgery
- Breast Surgery
- Vascular Surgery
- Thoracic Surgery
- Gynecological Surgery
- Bariatric Surgery
- Cardiac Surgery
- Gastrointestinal Surgery
- Urological Surgery
Minimally
Invasive Surgery Market, by Geography
- North America
- Europe
- Asia-Pacific
- Rest of the World (RoW)
About Us :
Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers.
We are privileged with highly experienced team of Analysts, Researchers and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge
Contact Us:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http:/www.transparencymarketresearch.com/
Life Sciences BPO Market Contract Research Organizations and Contract Manufacturing Organizations - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
Contract
manufacturing is a concept favored by the recent army of big and
successful manufacturers. Reducing cost helps a company to assign its
investments into other areas like branding, marketing and other sales
promoting activities that require constant attention. Manufacturing
and research units are among the integral part of a company’s whole
business process. However, they can also run on their own once given
proper direction, as they do not require constant tweaking, nor
involve sudden change in requirements in comparison to other
segments. A research unit particularly is nearly independent once a
project is initiated.
Browse Here For Full Report With
ToC:http://www.transparencymarketresearch.com/life-sciences-bpo-market.html
These
processes would only lead to a better product, and not necessarily, a
better brand presence or market share, both of which require great
deal of planning and routine changes of strategies in case something
goes different than expected. Most pharmaceutical and medical device
giants have adopted the strategy of outsourcing to specialist service
providers such as contract manufacturing organizations (CMOs) and
contract research organizations (CROs). Besides cost, these CMO’s
help reduce stagnancy in productivity volume and cost pressures and
arrest the concerns for any regulatory changes. The recent economic
downturn, rise in demand for generic drugs and patent expirations
have compelled the pharmaceutical companies to outsource their R&D
and manufacturing activities to such CMO’s.
We are currently offering a flat 15% discount on all purchases
until end of the March 2015!
The
life sciences BPO market comprises services offered by contract
manufacturing organizations (CMOs) and contract research
organizations (CROs) to the biotech/pharmaceutical companies.
Pharmaceutical companies are now forming long-term partnership with
the CROs and CMOs to share the costs involved in drug discovery to
post marketing approvals. Moreover, they are also leveraging CROs and
CMOs expertise such as use of novel technologies, trained staff and
previous experiences for effective outcomes.
This
research report provides a detailed analysis of the global life
sciences BPO market and helps in understanding the various driving
factors for the growth of the market. The market overview section of
this report analyzes the market dynamics and trends such as drivers,
restraints and opportunities that influence the current nature and
future status of this market. The executive summary provides detailed
insights about the report and the market in general. It also provides
a market snapshot, which in ways a glimpse into the present scenario
of the life sciences BPO market. Impact factors such as market
attractiveness analysis and Porter’s five forces analysis have also
been explained in the market overview section of the report in order
to deliver a thorough analysis of the overall competitive scenario of
the global life sciences BPO market.
The
report further discusses the market of life sciences BPO on the basis
of different CRO and CMO services. The CRO services comprise of
clinical data management, monitoring, medical writing, regulatory
services, pharmacovigilance, bio-statistics, drug discovery and
pre-clinical tests. The CMO services include API manufacturing,
finished dosage formulation development and manufacturing and
packaging.
Click Here For Upcoming Health care IT Reports
:http://www.transparencymarketresearch.com/healthcareit-market-reports-19.html
The
global life sciences BPO market has been segmented based on all the
above- mentioned parameters and market size estimates and forecasts
for the period of 2013 to 2019 have been provided for each of the
segments, in terms of USD million, considering 2012 as the base year
for calculations and 2011 representing as the historical year. The
CAGR (%) of each market segment for the forecast period 2013 to 2019
has also been provided along with market size estimations.
The
report exclusively studies the aforementioned segments with respect
to geography. Under geographic market section, four regional markets,
namely, North America, Europe, Asia-Pacific and Rest of the World
(ROW) have been analyzed. Moreover, the European region has been
further studied by various countries including U.K., Germany, France,
Spain, Italy and Rest of Europe (ROE).
The
report concludes with the competitive landscape and company profiles
of major market players. These market players have been profiled
based on various attributes such as company overview, financial
overview, business strategies, product portfolio and recent
developments. Some of the major players profiled in this report
include Catalent Pharma Solutions, Inc., PRA International, Inc.,
Covance, Inc., Cognizant Technology Solutions, Quintiles
Transnational Corporation, Parexel International Corporation, DSM,
Charles River Laboratories, Piramal Healthcare and Boehringer
Ingelheim GmbH.
About Us :
Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers.
We are privileged with highly experienced team of Analysts, Researchers and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge
Contact Us:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http:/www.transparencymarketresearch.com/
Hospital Acquired Disease Testing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
This
report covers the market analysis for various diagnostic tests
performed to detect hospital associated infections, also called as
nosocomial infections. These infections are not present in an
individual before being admitted to hospital; instead the infections
are developed after the admittance. Pathogens, primarily viral,
bacterial and fungal are the main cause for the prevalence of
nosocomial infections as they spread easily through the individual’s
body and thereby deteriorate the immune system. The infections are
mainly acquired from other patients, hospital staff, and contaminated
objects, acting as potential vectors. Morbidity rate of nosocomial
infections is increasing rapidly worldwide, hence driving the
hospital associated infection (HAI) diagnostic market towards
remarkable growth. The stakeholders for this study include
manufacturers and providers of diagnostic solutions for nosocomial
infections. Therefore, the global hospital acquired disease testing
market possesses tremendous growth potential, especially in the
developing nations.
Browse Here For Full Report With
ToC:http://www.transparencymarketresearch.com/hospital-acquired-disease-testing.html
This
research report provides a detailed analysis of the global hospital
acquired disease testing market and also aids in understanding the
various driving factors for the growth of this market. The executive
summary comprises the market snapshot which provides information
about segments and sub-segments. The market overview section of the
report demonstrates market dynamics and market trends such as the
drivers, restraints and opportunities that influence the current
nature and future status of this market. Impact factors such as
market attractiveness analysis and Porter’s five forces analysis of
key market players have also been explained in the market overview
section of the report, in order to give a thorough analysis of the
overall competitive scenario in the hospital acquired disease testing
market. All these factors would help the market players to gain
thorough analysis of the overall competitive scenario and thereby
decide upon the business strategies and plans to be incurred in
future for the global hospital acquired disease testing market.
“We are currently offering a flat 15% discount on all purchases
until end of the March 2015!”
The
global hospital acquired disease testing market is categorized on the
basis of infection types and geography. The market estimates from
2011 to 2019 for each of these segments is provided in USD million.
The global hospital acquired disease testing market, based on the
type of infection is segmented into urinary tract infection (UTI)
testing, surgical site infection(SSI) testing, pneumonia testing,
blood stream infection (BSI) testing, methicillin-resistant
staphylococcus aureus (MRSA) testing, and others (GI, bone,
respiratory, cardiovascular, etc.). A detailed market analysis and
forecast for these segments has been provided in this study in terms
of market revenue (USD million) for the period 2011 to 2019. The
report also provides the compounded annual growth rate (CAGR %) for
each infection type for the forecast period 2013 to 2019, while
market size estimations have been made considering 2012 as the base
year.
Based
on geography, the global hospital acquired disease testing market has
been segmented into four major regions: North America, Europe, Asia
Pacific and Rest of the World. The current and future market sizes
(in terms of USD million) of the above regional markets have been
provided in the report for the period 2011 to 2019 with their growth
rate (%) for the period 2013 to 2019. The study further offers
recommendations and highlights of the market, which would be useful
for the existing and new market players to sustain and grow in the
global hospital acquired disease testing market.
Click Here For Press Release
: http://www.transparencymarketresearch.com/pressrelease/hospital-acquired-disease-testing.htm
This
report concludes with the company profiles section which includes key
information such as company overview, financial overview, product
portfolio, business strategies and recent developments about the
major market players in hospital acquired disease testing market.
Some of the key players profiled in this report include Diatherix
Laboratories, Inc., Gen-Probe, Inc., Qiagen GmbH, L Hoffman La
Roche,Cepheid, Inc., Life Technologies Corporation, Meridian
Biosciences, Cantel Medical Corporation, Nordion, Inc.and others.
Drugs of Abuse Testing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2018
The
global drugs of abuse testing market is rapidly growing due to the
rising awareness of government and non-government organizations
towards ill effects of illicit drugs and to control socio-economical
losses associated with drug abuse. Globally rising consumption of
illicit drugs, adoption of drug of abuse (DOA) testing at
organizational level, increased production of illicit drugs and their
trade and increasing death rates/road accidents due to drug abuse is
also supporting the growth of the drugs of abuse testing market.
Urine
is the largest sample which is diagnosed in the drugs of abuse
testing market and it is expected to grow at a CAGR of 5.0% during
2013 – 2018. The other major samples for drugs of abuse testing are
Saliva and Hair. This report forecasts future potential of all these
drugs of abuse testing markets and analyses drivers and
opportunities, restraints and challenges, market trends, Porter’s
forces, competitive landscape and company profiles of key players.
Browse
Here for Full Reports With ToC:
http://www.transparencymarketresearch.com/drugs-abuse-testing-market.html
The
report categorizes the global drugs of abuse testing market based on
their type and geography. Laboratory based drug of abuse testing
requires a trained and skilled person to provide an accurate result
and involves in-depth analysis. In laboratory screening test, usually
the test is reconfirmed using gas chromatography/mass spectrometry or
any other superior techniques to provide accurate results. On-site
drugs of abuse testing gives results on the spot and is generally
preferred for those who take the drug test at home, workplace and
educational institutions. The most common specimens used in on-site
drugs of abuse testing are urine, saliva and hair. Nowadays,
commercially-available on-site drugs of abuse screening test kits are
usually designed for urine and saliva specimens only. In the segment
of geographic analysis, the report identifies and analyses drugs of
abuse testing market sizes and forecast of North America, Europe,
Asia Pacific and Rest of the World (RoW). North America region covers
the scenario of the US. Europe region covers the scenario of France,
Germany and the UK. Asia Pacific region highlights the scenario of
India, China and Japan.
We are currently offering a flat 15% discount on all purchases
until end of the March 2015!
About Us:
Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers.
We are privileged with highly experienced team of Analysts, Researchers and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Contact :
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http:/www.transparencymarketresearch.com/
Contact Lens Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
The
study on the global contact lens market segments the market by
design, usage, characteristics and geography to study each segment in
further detail. The report forecasts that the global contact lens
market will grow at a promising CAGR of 10.3% from 2013 through 2019.
This study discusses driving and restraining factors that will be at
play in the contact lens market worldwide over the forecast period.
Forecasts are provided in value (USD million) and the CAGR of each
geographical market and segment within the contact lenses market has
been stated in %.
A
side from conducting a qualitative analysis of the growth drivers and
inhibitors, the report features a PESTLE analysis to arrive at the
current and future status of geographical markets. TMR’s analysts
use their extensive market research capabilities to provide
recommendations to both established and new entrants in the market.
Browse
Here For Full Report With
ToC:http://www.transparencymarketresearch.com/contact-lens-market.html
Overview
of the contact lenses market
The
global contact lens market is projected to be valued at US$13.47
billion by 2019. Contact lenses are used for a variety of reasons,
including but not limited to: vision problems, ophthalmic disorders,
and fashion or accessories. This market will grow because of three
key uses of such lenses – cosmetic, aesthetic, and therapeutic.
Typically,
a contact lens is a small, thin and curved a prescription lens that
is won over the cornea. Besides being extensively used for refractive
error correction, contact lenses are becoming popular for cosmetic
use and as novelty products. For example, colored lenses or costume
lenses are worn as a fashion statement or to enhance eye color. In
2004 alone, nearly 125 million people were estimated to be using
these lenses, according to a Contact Lens Spectrum study. Since then,
this market has grown by leaps and bounds, especially after
widespread marketing and advertising campaigns by advertising
companies led to higher awareness.
We
are currently offering a flat 15% discount on all purchases until end
of the March 2015!
The
report also discusses aspects that could hold back the market from
reaching its full growth potential. One of the main deterrents is
improper handling of lenses leading to eye infections (causing
blindness in severe cases). Such cases could discourage consumers
from switching to contact lenses.
Segmentation
of the contact lens market
The
report segments the global contact lens market as by characteristics
as: toric, spherical, gas-permeable, and soft contact lenses. Soft
lenses are made from flexible plastics and are more comfortable. As
compared to the rigid gas permeable type, the soft lenses are also
easy to wear, making them the highest-growing segment over the
forecast period.
Despite
rigid gas permeable lenses being more durable (than soft lenses),
their demand will slump over the forecast period. This will largely
be because soft disposable lenses align better with changing
lifestyles. The soft lens market is composed of lens types such as:
weekly replacement, daily replacement, monthly replacement, annual
replacement, extended wear, and lenses with an unplanned replacement
schedule. The sub-segment of extended wear soft lenses and daily
disposable contact lenses occupied the largest market share in 2012.
However, the emphasis is now shifting towards high-comfort soft
lenses over hard lenses.
Browse
Here For Upcoming Reports
:http://www.transparencymarketresearch.com/medical-devices-market-reports-6.html
The
market can also be segmented by vision correction design as: toric,
spherical, and multifocal lenses
Geographical
overview of the contact lens market
According
to the findings of this study, North America and Europe constituted
over 70% of the total contact lens markets as of 2012. The high
number of people suffering from—and availing treatment
for—ophthalmic disorders has driven the market in Europe and North
America.
Over
the forecast period, rapid growth will be observed in the Asia
Pacific contact lens market, as massive untapped market potential
exists here. The opportunities have attracted several large players
to invest in markets such as China and India.
Companies
profiled in the global contact lens market report
Leading
companies that have been featured in the report include: Johnson &
Johnson (ACUVUE brand), Essilor International (ContinuVu Concentric
Design, Scone Standard), CIBA Vision (CIBA Vision Focus Dailies, CIBA
Vision Freshlook), and Cooper Vision (Biofinity Brands, Avira
Brands).
The
global contact lens market is segmented as follows:
Contact
Lens Market, by Characteristics
- Spherical Contact Lens
- Toric Contact Lens
- Gas-Permeable Contact Lens
- Soft Contact Lens
- Daily Disposable
- Weekly Replacement
- Monthly Replacement
- Extended Wear
- Annual Replacement
- Unplanned Replacement Schedule
Contact
Lens Market, by Design
- Spherical Contact Lens
- Toric Contact Lens
- Multifocal Contact Lens
- Orthokeratology Contact Lens
Click
Here For Requesting
Sample:http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1787
Contact
Lens Market, by Usage
- Corrective Contact Lens
- Therapeutic Contact Lens
- Post-Operative Therapeutic Contact Lens
- Cosmetic Contact Lens
- Enhancement Tints
- Opaque and Special Effect Contact Lens
- Prosthetic Contact Lens
- Computer Lens
- D-Segment Contact Lens
- Sports Lens
- Custom-made Contact Lens
Contact
Lens Market, by Geography
- North America
- Europe
- Asia-Pacific
- Rest of the World (RoW)
About Us:
Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers.
We are privileged with highly experienced team of Analysts, Researchers and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Contact :
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http:/www.transparencymarketresearch.com/
Subscribe to:
Posts
(
Atom
)
